The time course of CTLA4Ig effect on cardiac allograft rejection

Journal of Surgical Research

Volumn 63, Issue 1, 1996, Pages 320-323

  Bolling, Steven F ^a,b   Lin, Hua ^a   Turka, Laurence A ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; T LYMPHOCYTE RECEPTOR; ABATACEPT; ANTIBODY CONJUGATE; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BROWN NORWAY RAT; DRUG ADMINISTRATION; DRUG EFFECT; IMMUNOLOGY; LEWIS RAT; TIME;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; DRUG ADMINISTRATION SCHEDULE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; MALE; RATS; RATS, INBRED BN; RATS, INBRED LEW; TIME FACTORS;

EID: 0029665801     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0268     Document Type: Conference Paper

References (23)

1. Marrack, P., and Kappler, J. The T cell receptor. Science 238: 1073-1079, 1987.
2. Schwartz, R. H. A cell culture model for T lymphocyte clonal anergy. Science 248: 1349, 1990.
3. Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., and Ledbetter, J. A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173: 721-730, 1991.
4. Linsley, P. S., Brady, W., Urnes, M., et al. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174: 561-569, 1991.
5. Linsley, P. S., Clark, E. A., and Ledbetter, J. A. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. U.S.A. 87: 5031, 1990.
6. Austyn, J. M., Kupiec-Weglinski, J. W., Hankings, D. F., and Morris, P. J. Migration patterns of dendritic cells in the mouse. J. Exp. Med. 167: 646, 1988.
7. Larsen, C. P., Morris, P. J., and Austyn, J. M. Migration of dendritic leukocytes from cardiac allografts in host spleens. J. Exp. Med. 171: 307, 1990.
8. Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Gribben, J. G., Ng, J. W., Kim, J., Goldberg, J. M., Hathcock, K., Laszlo, G., et al. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178(6): 2185-92, 1993.
9. Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A., Jr., Lombard, L. A., Gray, G. S., and Nadler, L. M. Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262(5135): 909-911, 1993.
10. Lin, H., Bolling, S. F., Linsley, P. S., Wei, R. Q., Gordon, D., Thompson, C. B., and Turka, L. A. Long-term tolerance to major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor specific transfusion. J. Med. Exp. 178: 1801-1806, 1993.
11. Mason, D. W. Effector mechanisms in allograft rejection. Ann. Rev. Immunol. 4: 119, 1986.
12. Harding, F. A., McArthur, J. G., Gross, J. A. et al. CD28-mediated signalling costimulates murine T cells and prevents induction of anergy in T cell clones. Nature 356: 607, 1992.
13. Thompson, C. B., et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Sci. USA 86: 1333, 1989.
14. Turka, L. A., Linsley, P. S., Lin, H., Brady, W., Leiden, J. M., Wei, R. Q., Gibson, M. L., Zheng, X-G., Myrdal, S., Gordon, D., Bailey, T., Bolling, S. F., and Thompson, C. B. T cell activation by the CD28-ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. U.S.A. 89: 11102-11105, 1992.
15. Bolling, S. F., Lin, H., Wei, R. Q., Linsley, P., and Turka, L. A. The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival. J. Surg. Res. 57: 60-64, 1994.
16. Dallman, Margaret, J., Shiho, Osamu, and Hage, Theresa H. et al. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J. Exp. Med. 173: 79-87, 1991.
17. + T cells. J. Exp. Med. 173: 759-762, 1991.
18. De Wall, M. R., Haanen, J., Spits, H., Roncarolo, M.-G., Te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., and De Vries, J. E. 1991. IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of Class II MHC expression. J. Exp. Med. 915-924, 1994.
19. Schwartz, R. H. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71(7): 1065-1068, 1992.
20. de Boer, M., Kasran, A., Kwekkeboom, J., Walter, H., Vandenberghe, P., and Ceuppens, J. L. Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur. J. Immunol. 23(12): 3120-3125, 1993.
21. Lu, P., Zhou, X., Chen, S. J., Moorman, M., Morris, S. C., Finkelman, F. D., Linsley, P., Urban, J. F., and Gause, W. C. CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J. Exp. Med. 180(2): 693-698, 1994.
22. Lu, P., Zhou, X. D., Chen, S. J., Moorman, M., Schoneveld, A., Morris, S., Finkelman, F. D., Linsley, P., Claassen, E., and Gause, W. C. Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevations during a primary systemic in vivo immune response. J. Immunol. 154(3): 1078-1087, 1995.
23. Kuiper, H. M., Brouwer, M., Linsley, P. S., and van Lier, R. A. Activated T cells can induce high levels of CTLA-4 expression on B cells. J. Immunol. 155(4): 1776-1783, 1995.